VRAX

Virax Biolabs Group Ltd - Class A (VRAX)

Healthcare • NASDAQ$0.17+26.67%

Key Fundamentals
Symbol
VRAX
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Price
$0.17
Daily Change
+26.67%
Market Cap
$1.27M
Trailing P/E
N/A
Forward P/E
-0.71
52W High
$1.20
52W Low
$0.10
Analyst Target
$1.00
Dividend Yield
N/A
Beta
1.05
About Virax Biolabs Group Ltd - Class A

Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics. The company offers various in-vitro diagnostics test kits comprising respiratory, pregnancy and fertility, infectious diseases, sti, drugs of abuse, oncology, cardiac, women's health, other test kits under the ViraxClear brands; and rapid and molecular tests for small animal veterinary diagnostics under the ViraxVet brand. It also provides ViraxImmune, a T cell In vitro diagnostic device and wellness mobile application; and service, such as antibody engineering, custom peptides, protein sequencing, vaccine efficacy testing, immunology lab services, kits and reagents. In addition,

Company website

Research VRAX on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Terms · Privacy · ·

Loading...